Skip to content
ComeplyComeply

Insights

Product, AI, and compliance intelligence.

Featured

The draft Annex 11: what changes, and why we wouldn't wait for the final text

The draft revision of EU GMP Annex 11 goes from about five pages to nineteen. It isn't final yet, but most of what it asks for lands in SOPs you already own.

Compliance·September 30, 2026·5 min read·Christian Hyltoft
Read article
Compliance

Choosing your first eQMS as a life-science startup

Most startups need a quality system earlier than they planned. When the obligation starts, what to set up first, and what to check before you pick one. …

September 30, 2026·4 min read
Read article
Compliance

What FDA's Computer Software Assurance guidance does and doesn't change

CSA is final, it has already been reissued for the QMSR, and it gets misread a lot. What it asks for, who it formally applies to, and how it compares with EU expectations. …

September 30, 2026·4 min read
Read article
Compliance

Why compliance architecture needs to start earlier than you think

ICH E6(R3) raises a practical question for clinical teams: is compliance built into trial execution, or reconstructed after the fact? …

May 5, 2026·7 min read
Read article
Product Updates

Gap analysis without the guesswork

A useful gap analysis says where you are covered, where you are partial, and where you are exposed, instead of listing documents that look related. …

May 2, 2026·4 min read
Read article
AI Insights

AI in GxP environments: what explainability actually means

Regulated contexts require explainable AI: a team has to be able to trace an output back, review it, and get the same result again. …

May 2, 2026·6 min read
Read article